SALL4 and hepatocellular carcinoma: SALL4-based precision medicine relies on companion diagnostics to successfully select HCC patients who express high levels of SALL4; efforts are under way to develop an ultrasensitive peripheral blood protein assay to be used in conjunction with SALL4-targeting therapies.